Active Biotech AB Interim report January - June 2012
04:30 EDT 10 Aug 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Laquinimod - application submitted for regulatory approval in the EU resulting in milestone payment of USD 5 M during third quarter 2012 - a Phase III study will be initiated...
Other Sources for this Article
More From BioPortfolio on "Active Biotech AB Interim report January - June 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
